To evaluate the effect of supine position when compared with periodic change of position during phototherapy in late preterm and term neonates (35 to 42 weeks) with hyperbilirubinemia on the duration of phototherapy. STUDY DESIGN: We randomly allocated enrolled neonates with hyperbilirubinemia to either no change in position (supine group (SG); n ¼ 54) or two-hourly change of position from supine to prone and vice versa (turning group (TG); n ¼ 46). All the infants received single surface phototherapy by two dedicated compact fluorescent light units. Total serum bilirubin (TSB) was measured at the start of phototherapy and then every 12 ± 2 h until the end of phototherapy. Phototherapy was stopped when two values were below the cut-off for age and gestational age as per the American Academy of Pediatrics Subcommittee on Hyperbilirubinemia guidelines nomogram for the management of hyperbilirubinemia in infants 435 weeks of gestation. The primary outcome was duration of phototherapy and secondary outcome was rate of fall of bilirubin within the first 24 ± 2 h after the initiation of phototherapy. RESULT: Baseline characteristics including birth weight (g, 2752±478 vs 2748±416 P ¼ 0.96), gestation (week, 37.1±1.2 vs 37.4 ± 1.3, P ¼ 0.26) were similar in the two groups. There was no difference in the duration of phototherapy between the SG (mean ± s.d., hour, 25.5 ± 8) and TG (mean ± s.d., hour, 24.8 ± 5), mean difference (95% confidence interval), hour, 0.7 ( À 2.03, 3.44, P ¼ 0.6). Rate of fall of bilirubin was also similar in both supine and turning groups with mean difference of À 0.020 (95% confidence interval: À 0.061, 0.021, P ¼ 0.34). CONCLUSION: Nursing babies in supine position when compared with periodic position change during phototherapy does not decrease the duration of phototherapy.
INTRODUCTION
Ever since the advent of phototherapy as the modality of treatment of neonatal hyperbilirubinemia, 1 several studies have been conducted to improve its efficacy. The factors that affect the efficacy of phototherapy include spectrum of light used, intensity of phototherapy, the underlying cause of hyperbilirubinemia, initial total serum bilirubin (TSB) and the infant's body surface area exposed to phototherapy. 2 In addition to the above strategies, intermittent phototherapy and change in position seems to be possible intervention to improve the efficacy of phototherapy with an underlying biological rationale. Studies by Vogl et al. 3 and Lau et al. 4 have shown that intermittent phototherapy was as effective as continuous phototherapy. The explanation for this observation was that the blanched skin would be reloaded with bilirubin when phototherapy is stopped periodically during intermittent phototherapy, thus increasing the efficacy of phototherapy. The other logical alternative to this was to change position during phototherapy to expose the bilirubin-loaded side while the blanched side would be reloaded with bilirubin. Clinical data, however, does not support this biological rationale of periodic position change. [5] [6] [7] [8] There was some suggestion from earlier studies that position change did not enhance the efficacy of phototherapy. [5] [6] [7] These studies however lacked adequate power. The study done by Shinwell et al. 8 showed dramatically opposite results. It suggested supine position to be better than periodic position change. A recent study by Donneberg et al. 9 suggested that position change did not show any difference in outcome; however, this study did not report randomization or allocation concealment.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia guidelines (AAP, 2004) 10 and National Collaborating Centre for Women's and Children's Health guidelines on Neonatal jaundice (NICE (National Institute for Health and Clinical Excellence), 2010) 11 also do not have a consensus regarding positioning of the infant under phototherapy. Although NICE guidelines recommend supine positioning, AAP guidelines do not recommend any specific position for infants under phototherapy. In addition, prone position has the risk of sudden infant death syndrome. 12 Hence, concrete evidence in this aspect is lacking, and if available may enable to optimize the standard of care during phototherapy. Since studies done previously suggested that position change did not enhance efficacy of phototherapy, while study by Shinwell et al. showed supine position was better than position change, we hypothesized that supine position was superior to changing position at regular intervals. We designed an open label randomized controlled superiority trial to determine whether fixed position (supine only) was better than changing position at regular intervals.
METHODS

Subjects and setting
This open label randomized controlled trial was conducted in the neonatal intensive care unit at All Institute of Medical Sciences, New Delhi, India from June 2010 to July 2011. All neonates with neonatal hyperbilirubinemia requiring phototherapy as per AAP nomogram were screened, and those of age 424 h and o14 days were enrolled into the study. We excluded neonates with Rh hemolytic disease, positive direct Coomb's test and major congenital anomalies.
The study was approved by the ethics committee of the institute. Verbal and written informed consent was taken from parents before enrollment into the study. The study was registered in Clinical Trials Registry-India (http://www.ctri.nic.in: CTRI/2011/05/001727).
Randomization and intervention
Mothers of all neonates born between 35 and 42 weeks of gestation were given the information sheet at the time a decision of phototherapy was taken as per AAP guideline, and then a written consent was obtained from them.
We randomly allocated enrolled infants using computer-generated random sequence in two gestation strata (35 to 36 þ 6 weeks and X37 weeks) to either supine or turning every 2-h group. Allocation codes were kept in serially numbered, sealed, and opaque envelopes to ensure concealment and were opened by the duty resident. Owing to obvious nature of intervention, blinding was not possible in our study. All neonates enrolled in the study were nursed in neonatal intensive care unit to ensure strict compliance to the intervention.
After enrollment, all neonates were initially nursed in supine position. In the supine group (SG), the neonates were continued in the same position. In the turning group (TG), change of position from supine to prone and prone to supine was done every 2 h. As body surface area exposed during phototherapy in supine and prone position are similar (B35%), 13 turning the baby every 2 h from supine to prone and vice versa did not affect the body surface area exposed. Exclusive breast feeding was done on demand or every 2 h during the phototherapy in both the groups, and the time duration for feeding was recorded.
Single surface phototherapy was given using a phototherapy unit (Model CFL 100, Phoenix Medical System, Chennai, India), which has six light sources (Osram Dulux L 18 W/71, four blue compact fluorescent lights and two white compact fluorescent lights. The spectrum of light used was 425 to 475 nm, with the maximum adsorption peak at 450-460 nm. Two separate dedicated phototherapy units were used for the purpose of the study. Irradiance of the units was checked on 20 random neonates as a pilot study using neo BLUE LED phototherapy radiometer (Natus Medical, San Carlos, CA, USA) and was 20 to 25 mW cm À 2 nm À 1 . Bulbs were changed when irradiance was o20 mW cm À 2 nm
. Distance from phototherapy unit was fixed at 25 cm. All neonates were kept naked in the bassinet except for diapers and eye pads. Although white curtains used as reflectors would aid in reduction of serum bilirubin, it was not used as it would be difficult to monitor the position of the baby. 14, 15 Outcome variables and their measurements A team involving investigators were involved in training the nurses for the use of monitoring chart exclusively designed for the study. All the charts were regularly checked by the investigator whenever a neonate was enrolled in the study.
Duration of phototherapy was taken as the primary outcome of the study, as it is a clinically relevant outcome to assess the effect of intervention. It was calculated using nurses' monitoring chart, where the duration for which the baby was in the phototherapy unit and duration for which the baby was out of the phototherapy unit for the purpose of feeding or nursing were recorded by the neonatal nurse on duty. All the working nurses in the unit received prior training for filling up the proforma by the principal investigator, and their recordings were confirmed by the nursing in charge on duty. The method adopted for training of nurses to record the duration of phototherapy is displayed in panel 1.
The monitoring chart designed exclusively for the study was circulated among all the nurses working in neonatal intensive care units. A team involving the investigators was involved in training them on the use of the chart. After enrollment of the infants, the use of the monitoring chart was supervised for every baby by the resident doctor of the neonatal intensive care unit at the start of phototherapy and after three to four entries were made in the form for first 20 babies enrolled. The entries made were crosschecked by investigators on daily basis for the initial 20 babies enrolled and subsequently at regular intervals.
The secondary outcome was rate of fall of bilirubin. TSB was measured at every 12±2 h after initiation of phototherapy, using venous blood obtained in pre-heparinized capillaries. These samples were micro centrifuged at a speed of 9000 r.p.m. for 5 min and analyzed with spectrophotometer (Apel BR 5100, APEL, Kawaguchi, Japan). Calibration of the spectrophotometer was done at intervals, as recommended by the manufacturer.
Phototherapy was stopped when two values of TSB were below the cutoff for age and gestational age as per AAP nomogram for management of hyperbilirubinemia in infants 435 weeks of gestation. 10 After institution of phototherapy, the threshold for phototherapy initiation also changes with the increasing age of the infant, and so the bilirubin level cut-off for phototherapy corresponding to the current age of the infant in hours (AAP nomogram) was taken into consideration for stopping phototherapy. For example, if a baby born at 38 weeks of gestation with no risk factors had TSB of 17 mg dl À 1 at 48 h of life (corresponding cut-off for age as per AAP nomogram is 15 mg dl À 1 ), then phototherapy was initiated and serum bilirubin was measured every 12 h, and once two values were below the cut-off for the corresponding age phototherapy was stopped.
Although Rh-incompatible and ABO-incompatible babies were excluded from the study, peripheral smear examination of all the babies enrolled in the study was done to rule out hemolysis. Glucose-6-phosphate dehydrogenase screening of every infant was done to rule out hemolytic cause of hyperbilirubinemia. All infants who were deficient for glucose-6-phosphate dehydrogenase or had hemolysis on peripheral smear examination were continued on phototherapy and were followed-up until phototherapy was stopped. They were included in analysis with the intention to treat.
In addition, we monitored for any side effects like hyperthermia and rash during phototherapy.
Statistical analysis
Analysis was done using Stata 11.2 (Stata, College station, TX, USA). Baseline categorical variables were compared using w 2 -test/Fisher's exact test wherever appropriate, whereas continuous variables were compared using Student's t-test. P-value of o0.05 was considered as significant. The analysis was by intention to treat.
To determine sample size, we performed a pilot study on eight patients. Supine position indicated 13.8 h lesser duration of phototherapy (38.4 h in the TG vs 24.6 h in the SG) with a s.d of 15 h. Even taking a s.d. of 20 h, with a two-sided alpha error of 0.05 and power of 90%, we required to enroll 46 patients per group to detect a difference to this extent between the two groups. A total of 100 patients were randomized. Figure 1 shows the flow of the study. A total of 238 patients were screened and 100 were enrolled in the study. After stratified randomization, 54 neonates were enrolled in SG and 46 neonates were enrolled in TG. Baseline characteristics including gestational age, birth weight, TSB at the beginning of phototherapy and packed cell volume were comparable between the two groups ( Table 1) . Stratified randomization ensured similar enrollment of late preterm (35 to 36 þ 6 weeks of gestation) and term infants (437 weeks of gestation) in both the groups.
RESULTS
We did not find any difference in the primary outcomeduration of phototherapy-between SG (mean±s.d., hours, 25.5±8) and TG (mean±s.d., hours, 24.8±5); mean difference (95% confidence interval), hours, 0.7 ( À 2.03, 3.44) ( Table 2 ). There was no difference in the rate of fall of bilirubin in first 24 h after starting phototherapy between SG and TG with mean difference of À 0.02 and 95% confidence interval of À 0.06 to 0.02. TSB at the end of phototherapy was also similar in both SG and TG (mean difference, À 0.04 ( À 0.8, 0.9)).
Among all the neonates screened, 16 patients were glucose-6-phosphate dehydrogenase deficient. Four patients (two in each group) required double-unit intensive phototherapy in view of rising bilirubin values despite being on single-unit phototherapy; three of them had glucose-6-phosphate dehydrogenase deficiency and one had evidence of hemolysis in peripheral smear. There were no side effects of phototherapy in any of the neonates enrolled in the study.
DISCUSSION
Our study showed that position change during phototherapy did not influence the duration of phototherapy or the rate of Figure 1 . Flow of the study. Abbreviations: AFD, appropriate for dates; G6PD, glucose-6-phosphate dehydrogenase; LFD, large for dates; PCV, packed cell volume; SFD, small for dates. Data expressed as number (%) or mean±s.d.
Effect of infant position in hyperbilirubinemia management S Bhethanabhotla et al fall of bilirubin. There was no difference in the TSB at the end of phototherapy in both groups. These results are in accord with the results of previous studies. [5] [6] [7] 9 Yamauchi et al. 5 suggested that six-hourly position change when compared with no change in position in term neonates did not decrease the serum bilirubin concentration during or within 24 h after phototherapy. Chen et al. 6 and Mohammadzadeh et al. 7 also reported similar findings with two-and three-hourly position change, respectively, on mean change in serum bilirubin 6, 7 and duration of phototherapy. 6 A recent study by Donneberg et al. 9 in 112 neonates born at X33 weeks also suggests similar findings; however, some of these studies lacked adequate power because of a small sample size, [5] [6] [7] [8] did not report allocation concealment and randomization, [5] [6] [7] [8] [9] measured only transcutaneous bilirubin 5 or all the neonates received phototherapy for 24 h, irrespective of bilirubin values. 9 Majority of the studies either did not report the type of feeding [5] [6] [7] [8] or formula feeding was the predominant mode of feeding. 9 The above clinical data including the findings from our study do not support the biological rationale for position change proposed by Vogl et al. 16 This model assumes that the outermost 2 mm is the site of action of phototherapy and there is no lateral diffusion of bilirubin from unexposed skin to the adjacent exposed skin. Studies by Vogl et al. 3 and Lau et al. 4 suggest that intermittent phototherapy may perhaps be better for decreasing serum bilirubin values. It is proposed in this model that photodegradation of bilirubin is a two-step process; the first step is conversion of bilirubin to photo isomers, which occurs in nanoseconds, whereas the second step is migration of these photo isomers into circulation and the simultaneous migration of nonisomerized serum bilirubin to the skin. The latter step is considered rate limiting as the time required for the second step is estimated to be 1-3 h, and hence the proposal of changing position during phototherapy as suggested in this model seems reasonable. The clinical data (including our study) does not support position change. This finding may be explained by the suggestion of that bilirubin migration being a dynamic process. 17 The decrease in the bilirubin in the unexposed part during phototherapy is proposed to be due to establishment of a new gradient between the bilirubin deposited in the unexposed area and intravascular compartment, leading to gradual efflux of bilirubin from unexposed skin.
The study done by Shinwell et al. 8 suggested supine position to be superior to position change; they proposed a modification of the previous model. Bilirubin molecules in the extravascular space function as a filter avoiding interaction of photons with bilirubin in the intravascular space; blanching of skin helps photons directly penetrate the skin and reach the intravascular bilirubin. Thus, there is a probability of increasing the efficacy of phototherapy by placing infants in supine position. This effect may be further enhanced by hyperemic effect of phototherapy. Our study suggested no difference in the duration or the rate of fall of bilirubin; thus the actual effect on bilirubin decline may be interplay of the above proposed models.
The strength of our study is its robust design. None of the previous studies reported randomization. Most of the studies done previously either reported mean fall in bilirubin over a period of time or duration of phototherapy. Another major strength of our study is meticulous calculation of duration of phototherapy using the monitoring chart, thereby excluding the time duration for which the baby was out of the phototherapy unit. This enabled us to minimize bias in results.
CONCLUSION
It can be concluded from our study that nursing neonates in supine position does not affect the duration or rate of fall of bilirubin when compared with regular position change. In view of risk of sudden infant death syndrome in prone position and increased demand for monitoring in otherwise healthy neonates, changing position from supine to prone and vice versa seems to be unnecessary.
Summary What is already known
Efficacy of phototherapy can be enhanced by increasing surface area exposed. Role of position of infant during phototherapy in optimizing its efficacy still remains unanswered.
What this study adds
Nursing neonates in supine position during phototherapy does not increase the duration of phototherapy. Effect of infant position in hyperbilirubinemia management S Bhethanabhotla et al
